drugset / Trial / NCT00387283
Pharmacokinetic Study in Cerebral Spinal Fluid After a Single Dose of AVI-4020
Non-randomizedSingle-groupOpen-labelTreatment
Summary
During a clinical study of people with severe West Nile virus infections, it was determined that the drug AVI-4020 crossed the blood-brain barrier. This study will assess the amount of drug that goes across the blood-brain barrier and the drug levels measured in both the blood and urine. The objective of this study is to find out how much and how fast this drug crosses this barrier.
Timeline
- Start
- 2006-10
- Primary completion
- 2006-12
- Completion
- 2009-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AVI-4020 | Oligonucleotide (other) | — | Intravenous |